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SCIENTIFIC OPINION 
Scientific Opinion on the safety of UV-treated bread as a novel food
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and 
Allergies (NDA Panel) was asked to carry out the additional assessment for UV-treated bread as a novel food 
(NF) in the context of Regulation (EC) No 258/97, taking into account the comments and objections of a 
scientific nature raised by Member States. The NF is bread to which a treatment with UV radiation is applied 
after baking in order to convert ergosterol, which is present in bread as a result of yeast fermentation, to 
vitamin D2. The provided compositional data, the specifications (i.e. vitamin D2 content of 0.75–3 μg/100 g in 
the UV-treated bread, 1–5 g/100 g of yeast in the dough) and the data from batch testing do not give rise to 
safety concerns. The data provided on the production process are sufficient and do not give rise to safety 
concerns. The Panel considers that even if it is conservatively assumed that all consumed breads are UV-treated 
and contain the maximum proposed amount of 3 µg vitamin D2/100 g, it is highly unlikely that tolerable upper 
intake levels for vitamin D, established by EFSA for various age groups, will be exceeded. The NF is not 
nutritionally disadvantageous. Under certain conditions, UV treatment may result in reactions of biomolecules. 
However, the levels of potential reaction products that may be formed under the employed conditions are low 
compared with the reactions induced by the baking process. Therefore, the Panel considers that it is not 
necessary to perform additional analyses and that the absence of toxicological studies with the novel food is 
acceptable. The risk of allergic reactions to the NF is not dissimilar to that associated with conventional bread. 
The Panel considers that bread enriched with vitamin D2 through UV treatment is safe under the conditions of 
use as specified by the applicant. 
© European Food Safety Authority, 2015 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA Panel) was asked to carry out the additional assessment for UV-treated bread as a 
novel food (NF) in the context of Regulation (EC) No 258/97, taking into account the comments and 
objections of a scientific nature raised by Member States. 
The NF is bread to which a treatment with UV radiation is applied after baking in order to convert 
ergosterol, which is present in bread as a result of yeast fermentation, to vitamin D2 (ergocalciferol). 
Specifications of the NF include the intended vitamin D2 content (0.75–3 μg/100 g) in the UV-treated 
bread and the amount of yeast (1–5 g/100 g) required in the dough in order to achieve the amount of 
vitamin D2. 
The applicant provided compositional data on macro- and micronutrients in various types of bread 
subjected to the UV treatment at pilot and commercial scale. The UV-treated breads contained 
significant amounts of vitamin D2, while the contents in the control breads were below the limit of 
detection. The contents of water, protein, fat, carbohydrate, fibre, different groups of fatty acids, 
vitamin E and B vitamins in the UV-treated breads were comparable to those in the control breads. 
The UV treatment results in the formation of vitamin D2 in only a thin outer layer (i.e. crust, 2–3 mm) 
of the bread. Peroxide values and folate contents in crust and crumb following UV treatment were 
comparable to those determined in the control. The Panel considers that the provided compositional 
data, the specifications and the data from batch testing do not give rise to safety concerns. 
The process conditions of the UV treatment have been provided by the applicant. The parameters of 
the process have to be adjusted on a case-by-case basis to achieve the target level of vitamin D2. 
Considering that there are no relevant changes in nutrient composition in the breads following the 
proposed UV treatment, the Panel considers the specified parameters, including the range of 
wavelength for the UV treatment, as acceptable. The Panel concludes that the data provided on the 
production process are sufficient and do not give rise to safety concerns. 
Based on available data from the EFSA Comprehensive European Food Consumption Database, the 
applicant provided intake estimates (mean and 95th percentile) of vitamin D2 from UV-treated bread 
under the assumption that all bread consumed was treated and contained the maximum proposed 
amount of vitamin D2 of 3 μg/100 g. The mean and 95th percentile vitamin D2 intake estimates range 
from 2.6 to 4.8 μg/day and 5.6 to 10.5 μg/day, respectively, for adults and the elderly, from 2.3 to 
4.3 μg/day and 3.6 to 8.8 μg/day, respectively, in adolescents and from 1.4 to 4.2 μg/day and 3.6 to 
7.2 μg/day, respectively, for children. The Panel considers that even if it is conservatively assumed 
that all consumed breads are UV-treated and contain the maximum proposed amount of 3 µg 
vitamin D2/100 g, it is highly unlikely that tolerable upper intake levels for vitamin D established by 
EFSA for children aged 1–10 years (50 µg/day) and adolescents and adults (100 µg/day) will be 
exceeded. 
Both Saccharomyces cerevisiae and vitamin D2 have a long history of food use. Saccharomyces 
cerevisiae has an extensive history of food use in the baking and brewing industries and has been 
categorised by EFSA as a microorganism that has Qualified Presumption of Safety (QPS) status. In the 
European Union (EU), vitamin D3 and vitamin D2 are authorised for use in food supplements and 
addition of vitamins and minerals to foods. 
UV-treated breads are comparable to untreated breads, except for the vitamin D2 content. No adverse 
effects regarding the contribution of bread to nutrient intakes are expected from the consumption of 
UV-treated bread in substitution of traditional bread. The Panel considers that the NF is not 
nutritionally disadvantageous. 
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The microbiological status of the bread is mainly determined by the thermal treatment in the course of 
the baking processing. The Panel considers that the data provided do not give rise to concerns with 
regard to the microbiological quality of the NF. 
The applicant has not carried out toxicological studies on the NF. The Panel is aware that, under 
certain conditions, UV treatment may result in reactions of biomolecules, such as lipids or proteins. 
However, the reactions potentially induced by the UV treatment have to be considered in the light of 
the preceding baking process. The levels of potential reaction products that may be formed under the 
employed conditions from UV-induced oxidative reactions are low compared with the reactions 
induced by the baking process. Therefore, the Panel considers that it is not necessary to perform 
additional analyses and that the absence of toxicological studies with the NF is acceptable. 
With regards to allergenicity, the Panel considers that the risk of allergic reactions to the NF is not 
dissimilar to that associated with conventional bread. 
The Panel considers that bread enriched with vitamin D2 through UV treatment is safe under the 
conditions of use as specified by the applicant. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
On 12 February 2014, the company Viasolde AB submitted a request in accordance with Article 4 of 
the novel food Regulation (EC) No 258/97
4
 to place on the market bread treated with UV light as a 
novel food ingredient. 
On 14 March 2014, the competent authority of Finland forwarded to the Commission its initial 
assessment report, which came to the conclusion that bread treated with UV light meets the criteria for 
acceptance of a novel food defined in Article (3)1 of Regulation (EC) No 258/97. 
On 19 March 2014, the Commission forwarded the initial assessment report to the other Member 
States. Several Member States submitted comments or raised objections. 
In consequence, a decision is now required by the Commission under Article 7(1) of Regulation (EC) 
No 258/97.  
The concerns of a scientific nature raised by the Member States can be summarised as follows: 
 There appears to be a lack of standardisation of the process. The uniformity of vitamin D 
content that would be obtained in commercial batches and compliance with the specifications 
in various batches of different breads throughout the life cycle of the product needs to be 
confirmed. Different levels of vitamin D may be formed depending on the characteristics of 
the bread. 
 There is no information on the peroxide value at the end of the shelf life of the bread. 
 Further information on the possibility of UV treatment to give rise to oxidation products or 
treatment-induced aggregates is requested. The potential cross-linking of proteins due to UV 
treatment, which could have specific allergic properties, is not addressed. The presence of 
degradation products of proteins, such as oligopeptides, amino acids or their UV-light 
oxidative transformation substances that may be of safety concern, is not addressed. 
 The potential formation of oxidation products of sterols, such as oxysterols, which show toxic 
characteristics, is not addressed. 
 The scientific literature describes the formation of mutagenic substances caused by UV 
irradiation, e.g. from the substance maltol, which is present in bread and baked goods. The 
applicant should be requested to provide an assessment of UV irradiation of bread, taking into 
account the effects of UV light on substances present in the bread crust, as described in the 
literature. 
 Sterilisation typically involves a wavelength of 254 nm, further justification for the broader 
wavelength range proposed (230–315 nm) and consideration on whether it raises safety 
concern are requested. 
 Information on whether the data relating to Nordic breads can be translated to other types of 
breads and whether UV treatment has any effects on the composition of these breads. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29(1)(a) of Regulation (EC) No 178/2002,
5
 the European Commission asks 
the European Food Safety Authority to provide a scientific opinion by carrying out the additional 
                                                     
4  Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and 
novel food ingredients. OJ L 43, 14.2.1997, p. 1–6. 
5  Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1–24. 
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assessment for bread treated with UV light as a novel food ingredient in the context of Regulation 
(EC) No 258/97. 
ASSESSMENT 
In accordance with Commission Recommendation 97/618/EC,
6
 bread enriched with vitamin D2 
through treatment with ultraviolet (UV) radiation (thereafter called UV-treated bread) is allocated to 
Class 6, i.e. “foods produced using a novel process”. The assessment of the safety of this novel food 
(NF) is based on data supplied in the original application, the initial assessment by the competent 
authority of Finland, the concerns and objections of the other Member States and the responses of the 
applicant. The data are required to comply with the information required for NFs of Class 6, i.e. 
structured schemes I, II, III, IX, X, XI, XII and XIII of Commission Recommendation 97/618/EC. In 
the text these structured schemes are listed 1 to 8. The intention is to market UV-treated bread for use 
as a source of vitamin D. This assessment only concerns risks that might be associated with 
consumption, and is not an assessment of the efficacy of UV-treated bread with regard to any claimed 
benefit. 
1. Specification of the novel food 
The NF is bread to which a treatment with UV radiation is applied after baking in order to convert 
ergosterol, which is present in bread as a result of yeast fermentation, to vitamin D2 (ergocalciferol). 
Specifications of the NF are provided in Table 1. They include the intended vitamin D2 content of the 
UV-treated bread and the amount of yeast required in the dough in order to achieve the amount of 
vitamin D2. 
Table 1:  Specifications of the UV-treated bread as proposed by the applicant 
Parameter Value Method 
Vitamin D2 (μg/100 g) 0.75–3 EN 12821, 2009
(a)
 
Yeast in dough (g/100 g) 1–5 Recipe calculation 
(a): European Standard 
Based on the performed tests the applicant proposed that the following bread types are subject to the 
UV treatment process: white bread (mainly from wheat flour), dark bread (wholly or partially with rye 
flour), wholemeal bread (wholly or partially with wholemeal flour), crisp bread, flatbread, sourdough 
bread as well as buns and bread rolls. 
The applicant provided compositional data on macro- and micronutrients in representative types of 
bread commonly eaten in Scandinavia that had been subjected to the UV treatment. Table 2 shows 
analytical results (based on single measurements per bread) for two white wheat breads, dark 
wholemeal bread with rye and wheat flatbread treated with UV using pilot scale equipment. The UV-
treated breads contained significant amounts of vitamin D2, while the contents in the control breads 
were below the limit of detection of 0.5 µg/100 g. The contents of water, protein, fat, carbohydrate, 
fibre, different groups of fatty acids, vitamin E and B-vitamins in the UV-treated breads were 
comparable to those in the control breads. The Panel notes the apparent variability in the folate content 
across the breads. 
                                                     
6  Commission Recommendation 97/618/EC: Commission Recommendation of 29 July 1997 concerning the scientific 
aspects and the presentation of information necessary to support applications for the placing on the market of novel foods 
and novel food ingredients and the preparation of initial assessment reports under Regulation (EC) No 258/97 of the 
European Parliament and of the Council. OJ L 253, 16.9.1997, p. 1–36. 
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Table 2:  Compositional data of different types of bread treated with UV (values per 100 g) 
Analyte White 1 White 2 Wholemeal Flat bread 
control UV
(a)
 control UV
(a)
 control UV
(a)
 control UV
(a)
 
Vitamin D2 (µg) ˂ 0.5 2.5 ˂ 0.5 2.7 ˂ 0.5 0.9 ˂ 0.5 5.3 
Water (g) 32.8 32.2 35.5 35.1 31.8 35.6 32.4 31.8 
Protein 
(N × 6.25) 
9.1 8.9 8.8 8.9 6.6 6.5 8.4 8.4 
Fat (g) 2.0 2.0 4.3 4.3 6.1 5.9 3.2 3.3 
SFA (%)
(b)
 15.0 15.0 10.1 10.3 11.4 11.2 13.7 13.5 
MUFA (%)
(b)
 37.0 37.1 52.9 52.9 32.5 28.2 46.5 46.5 
PUFA (%)
(b)
 46.9 47.1 36.4 36.2 55.4 59.2 38.9 39.0 
Carbohydrates 
(g)
(c)
 
50.2 51.5 45.6 46.1 39.4 39.8 52.0 52.6 
Fibre (g) 4.4 3.9 4.3 4.1 9.5 9.9 2.9 2.8 
Vitamin E (mg) 0.364 0.366 0.911 0.871 3.92 4.65 0.841 0.886 
Thiamine (mg) 0.088 0.088 0.087 0.082 0.168 0.168 0.133 0.130 
Riboflavin (mg) 0.040 0.040 0.030 0.020 0.040 0.040 0.020 0.020 
Niacin (mg) 2.82 2.81 2.78 2.80 3.29 2.96 2.90 2.83 
Pyridoxine (mg) 0.119 0.109 0.074 0.081 0.157 0.161 0.077 0.097 
Folate (µg) 60.9 49.7 32.6 33.2 26.3 27.6 28.2 34.1 
Methods: moisture, NMKL (Nordic Committee on Food Analysis) 23; crude protein (Kjeldahl), NMKL 6; fat, SLV VF 1980; 
SFA, AOCS (American Oil Chemists` Society) Cd 1c-85; MUFA, AOCS Cd 1c-85, PUFA, AOCS CD 1c-85; fibre, AOAC 
985.29 2003; vitamin E, EN 12822 2000; vitamin D2, EN 12581:2009-08; thiamine, EN 14122-2001 mod.; riboflavin, EN 
14152 mod.; niacin, AOAC 944.13/45.2.04 (1990); pyridoxine, EN 14164:2008; folate, AOAC 944.12/45.2.03 (1990). 
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids. 
(a): Energy inputs: white wheat breads (9 mJ/cm2), dark wholemeal bread with rye (18 mJ/cm2), wheat flatbread (4 mJ/cm2). 
(b): Expressed as % of total fatty acids. 
(c): Calculated from other analyses. 
The applicant also presented compositional data on three batches of wheat flatbread treated with UV at 
commercial production scale (Table 3). Except for one batch, the target content of vitamin D2 
(1 µg/100 g bread) was reproducibly achieved by the UV treatment. No consistent effects of the 
treatment were observed for the contents of thiamine, riboflavin, niacin and pyridoxine. For folate, the 
contents were also comparable to the control in two batches (B, C); the Panel notes the apparent 
variability in the folate content in samples from one of the batches (A). 
Safety of UV-treated bread  
 
EFSA Journal 2015;13(7):4148 8 
Table 3:  Compositional data of wheat flatbread treated with UV at commercial production scale 
(values per 100 g) 
Batch Thiamine 
(mg) 
Riboflavin 
(mg) 
Niacin (mg) Pyridoxine 
(mg) 
Folate (µg) Vitamin D2 
(µg) 
A 
Control A 0.133 0.030 0.878 0.0557 31.3 ˂ 0.25(a) 
1A 0.148 0.020 0.738 0.0458 19.4 1.09 
2A 0.151 0.030 0.738 0.0521 17.2 0.90 
3A 1.135 0.020 0.789 0.0506 18.5 0.98 
Average 0.145 0.023 0.770 0.0495 18.4 0.99 
B 
Control B 0.147 0.020 0.972 0.0554 27.1 ˂ 0.25 
1B 1.134 0.030 0.884 0.0479 28.7 0.96 
2B 0.148 0.030 0.799 0.0526 20.9 0.94 
3B 0.150 0.025 0.888 0.0564 27.4 1.03 
Average 0.144 0.028 0.857 0.0523 25.7 0.97 
C 
Control C 0.145 0.020 1.03 0.0527 23.2 < 0.25 
1C 1.133 0.020 0.949 0.0559 28.2 1.04 
2C 0.144 0.020 1.02 0.0472 25.7 0.69 
3C 0.135 0.020 1.06 0.0498 25.6 0.81 
Average 0.137 0.020 1.01 0.0510 26.5 0.85 
Conditions of treatment: 3 x 300 kg of dough resulting in 7 500 individual pieces of bread; UV-treated area (each piece): 
115x105x11 mm; energy input: 4.0 mJ/cm2; time of UV exposure: six seconds. 
Methods: vitamin D2, EN 12851:2009-08; thiamine, EN 14122:2001 mod.; riboflavin, EN 14152:2006, mod.; niacin, AOAC 
944.13 / 45.2.04 (1990); pyridoxine, EN 14164:2008; folate, AOAC 45.2.09 (2004).  
(a): limit of detection. 
The applicant provided analytical data on UV-treated hotdog buns demonstrating that the UV 
treatment results in the formation of vitamin D2 in only a thin outer layer (i.e. crust, 2-3 mm) of the 
bread surface. The content of vitamin D2 in the crust of the UV-treated hotdog buns amounted to 
37 µg/100 g whereas it was not detectable (< 0.5 µg/kg) in the crumb. Peroxide values and folate 
contents in crust and crumb of the UV-treated buns were comparable to those determined in the 
control. According to the applicant, peroxide values were determined three days after bread production 
and UV treatment; this is considered acceptable by the Panel. 
No specific data on the stability of the NF have been provided.  
The Panel considers that the provided compositional data, the specifications and the data from batch 
testing do not give rise to safety concerns. 
2. Effect of the production process applied to the novel food  
Bread is treated with UV after the baking process. Ergosterol, the pro-vitamin D2 generated by the 
yeast, is converted into vitamin D2 (ergocalciferol). The process conditions of the UV treatment, i.e. 
the time required, the distance of the UV source to the bread, the energy input and the range of 
wavelength, have been provided by the applicant. 
The parameters of the process have to be adjusted on a case-by-case basis to achieve the target level of 
vitamin D2. They depend on different factors, such as composition of the raw material, water content 
and size and shape of the type of bread. 
Considering that there are no relevant changes in nutrient composition in the breads following the 
proposed UV treatment, the Panel considers the specified parameters, including the range of 
wavelength for the UV treatment, as acceptable. 
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According to the applicant, the equipment used for UV irradiation can be adjusted so that the 
production of a specified level of vitamin D2 can be achieved with a maximum tolerance of ± 10 %. 
However, the applicant also emphasized that the process has to be set up and specifically standardised 
depending on the characteristics of the bread and proposed that adequate testing at a commercial 
bakery should be performed each time the process is applied for commercial scale operation. The 
applicant also stated that the vitamin D2 content of the final product will be analysed in each batch. 
Compositional data from batches obtained at commercial production scale demonstrated that the target 
amount of vitamin D2 can be reproducibly achieved (Table 3). The transformation of ergosterol to 
vitamin D2 occurs solely in a thin outer layer (2–3 mm) of the bread surface. 
Data obtained from analyses of different types of bread produced at pilot and commercial scale 
demonstrated that the UV treatment had no impact on the contents of macroconstituents (protein, fat, 
carbohydrates) and of microconstituents (vitamin E and B vitamins) (Tables 2 and 3). 
The applicant selected folate as the particular indicator for potential oxidative deteriorations induced 
by the UV treatment. Despite some analytical uncertainties, the data provided showed that there are no 
relevant changes in the content of this vitamin as a result of UV treatment (Tables 2 and 3). 
UV radiation in the range of 240–280 nm is lethal to most microorganisms. The maximum germicidal 
effect is achieved at 254 nm. Practical applications are the inhibition of microorganisms on surfaces, 
the inactivation of microorganisms in air and the sterilisation of liquids (Bintsis et al., 2000; Guerrero-
Beltrán and Barbosa-Cánovas, 2004; Koutchma, 2008). 
According to the United States Food and Drug Administration, UV radiation for the processing and 
treatment of food may be safely used for the following purposes: surface microorganism control in 
high fat-content food irradiated in vacuum or in an inert atmosphere; sterilization of water used in food 
production; reduction of human pathogens and other microorganisms in juice products (FDA, 2000). 
The Panel concludes that the data provided on the production process are sufficient and do not give 
rise to safety concerns. 
3. History of the organism used as a source  
Not applicable 
4. Anticipated intake/extent of the use of the novel food 
The applicant provided bread consumption data (mean and 95th percentile) from 13 European Union 
countries, for adults, the elderly, adolescents and children, from the EFSA Comprehensive European 
Food Consumption Database (FoodEx Level 2). High bread consumption was reported in Denmark, 
Germany, Ireland, the Netherlands and Eastern European countries (mean 138–160 g/day and 95th 
percentile 281–350 g/day in adults). The lowest bread consumption was reported in Spain (mean 
88 g/day and 95th percentile 192 g/day). The applicant also provided data separated by sex, based on 
published national consumption survey reports. Bread consumption was higher in males than in 
females for all age groups. 
Based on available data from the EFSA Comprehensive European Food Consumption Database, the 
applicant provided intake estimates of vitamin D2 from UV-treated bread under the assumption that all 
bread consumed was treated and contained the maximum proposed amount of 3 μg/100 g (Table 3). 
The mean and 95th percentile vitamin D2 intake estimates from the UV treated bread range from 2.6 to 
4.8 μg/day and 5.6 to 10.5 μg/day, respectively, for adults and the elderly, from 2.3 to 4.3 μg/day and 
3.6 to 8.8 μg/day, respectively, in adolescents and from 1.4 to 4.2 μg/day and 3.6 to 7.2 μg/day, 
respectively, for children. 
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The applicant also provided estimates by sex based on data from published national consumption 
survey reports, which were in the same order of magnitude. 
The Panel notes that the type of intake estimate provided by the applicant assumes that all bread 
consumed was UV-treated and contained the maximum proposed amount of 3 µg vitamin D2/100 g. 
The Panel therefore considers that this estimate significantly overestimates intakes. However, even if 
it is conservatively assumed that all consumed breads are UV-treated and contain 3 µg 
vitamin D2/100 g, it is highly unlikely that tolerable upper intake levels established by EFSA (EFSA 
NDA Panel, 2012) for children aged 1–10 years (50 µg/day) and adolescents and adults (100 µg/day) 
will be exceeded. 
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Table 4:  Estimated intake of vitamin D from UV-treated bread, based on data from the EFSA Comprehensive European Food Consumption Database 
 
Country Adults The elderly Adolescents Children 
Bread intake 
(g/day) 
Vitamin D 
intake 
(μg/day) 
Bread intake 
(g/day) 
Vitamin D 
intake 
(μg/day) 
Bread intake 
(g/day) 
Vitamin D 
intake (μg/day) 
Bread intake 
(g/day) 
Vitamin D 
intake 
(μg/day) 
Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 
Belgium 126 285 3.8 8.6 121 240 3.6 7.2 118 250 3.5 7.5 78 137 2.3 4.1 
The Czech Republic 159 341 4.8 10.2 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
Denmark 160 281 4.8 8.4 156 266 4.7 8.0 142 259 4.3 7.8 140 239 4.2 7.2 
France 109 252 3.3 7.6 138 297 4.1 8.9 78 192 2.3 3.6 48 120 1.4 3.6 
Germany 135 287 4.1 8.6 143 269 4.3 8.1 134 292 4.0 8.8 94 175 2.9 5.3 
Hungary 153 297 3.1 8.9 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
Ireland 138 281 3.1 8.4 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
Italy 114 350 3.1 10.5 124 260 3.7 7.8 111 241 3.3 7.2 81 185 2.4 5.6 
Latvia 144 350 4.3 10.5 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
Spain 88 192 2.6 5.8 n.a. n.a. n.a. n.a. 135 260 4.1 7.8 97 183 2.9 5.5 
Sweden 102 187 3.1 5.6 n.a. n.a. n.a. n.a. 76 149 2.3 4.5 62 128 1.9 3.8 
The Netherlands 153 300 4.6 9.0 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 62 128 1.9 3.8 
The United Kingdom 111 222 3.3 6.7 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
n.a., not available 
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5. Information from previous exposure to the novel food or its source 
Both Saccharomyces cerevisiae (S. cerevisiae) and vitamin D2 have a long history of food use. 
S. cerevisiae has an extensive history of food use in the baking and brewing industries. EFSA has 
categorised S. cerevisiae as a microorganism that has Qualified Presumption of Safety (QPS) status 
(EFSA BIOHAZ Panel, 2014). 
In Canada, the addition of vitamin D2-yeast to yeast-leavened bakery products has been permitted at a 
level up to 90 IU (International Unit) (2.25 µg) per 100 g of product (Health Canada, 2011). In the 
USA, the food additive regulations allow for the use of vitamin D2 baker´s yeast in yeast-leavened 
baked products at levels not to exceed 400 IU (10 μg) of vitamin D2 per 100 g of the finished food 
(FDA, 2012). In the EU, UV-treated baker´s yeast may be placed on the market as a novel food 
ingredient in yeast-leavened breads and rolls and in yeast-leavened fine bakery wares at maximum use 
levels of 5 µg of vitamin D2/100 g final product and in food supplements at a maximum use level of 
5 µg of vitamin D2/day (EU, 2014). 
In the EU, vitamin D3 and vitamin D2 are authorised for use in food supplements
7
 and addition of 
vitamins and minerals to foods.
8
 
6. Nutritional information on the novel food 
UV treatment for the purpose of reducing microorganisms has been reported to reduce vitamin 
contents in foods such as milk (Guneser and Karagul Yuceer, 2012) or juices (Tran and Farid, 2004; 
Bhat et al., 2011). For breads subjected to the specified UV treatment, analytical comparisons of the 
nutrient compositions, including B vitamins and folate, no relevant reductions were observed 
(Section 2.2). UV-treated breads are comparable to untreated breads, except for the vitamin D2 
content. No adverse effects regarding the contribution of bread to nutrient intakes are expected from 
the consumption of UV-treated bread in substitution of traditional bread. 
The Panel notes that current dietary reference values for children aged 1–18 years and for adults vary 
from 5 to 15 µg/day and from 10 to 20 µg/day, respectively (SCF, 1993; IoM, 2011; DACH, 2013; 
NNR, 2013). 
In 2012, EFSA estimated that the mean intake of vitamin D from foods among young children varies 
from 1.7 µg/day (Denmark, boys, 1–3 years) to 5.6 µg/day (Greece, 1–5 years) while the high 
percentile intake estimates vary from 2.4 µg/day (Denmark, 95th percentile, boys, 1–3 years) to 
11.9 µg/day (Greece, 90th percentile, 1–5 years) (EFSA NDA Panel, 2012). 
In adolescents, mean intake from foods varies from 1.6 µg/day (Spain, 11–17 years) to 4.0 µg/day 
(Belgium, boys, 13–18 years). Intakes at the 95th percentile were between 3.0 µg/day (Spain, 11–
17 years) and 7.7 µg/day (Italy, boys, 10 to ˂ 18 years, including fortified food). Mean or median 
intakes from foods and supplements and for the 95th percentile of consumption are within these 
ranges. 
For adults, estimates on mean intake of vitamin D from foods varied from 1.1 µg/day (Spain, women, 
18–64 years) to 8.2 µg/day (Finland, men, 25–74 years) and estimated 95th percentile intakes varied 
from 2.4 µg/day (Spain, women, 18–64 years) to 16.0 µg/day (Finland, men, 25–74 years). For those 
adults who also consume vitamin D from food supplements, intakes were estimated to be 1.5-fold 
higher. 
                                                     
7 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183, 12.07.2002, p. 51–57. 
8 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404, 30.12.2006, p. 26–38. 
Safety of UV-treated bread  
 
EFSA Journal 2015;13(7):4148 13 
Even if it is conservatively assumed that all consumed breads are UV treated and contain 3 µg 
vitamin D2/100 g, it is highly unlikely that tolerable upper intake levels established by EFSA (EFSA 
NDA Panel, 2012) for children aged 1–10 years (50 µg/day) and adolescents and adults (100 µg/day) 
will be exceeded. 
The Panel considers that the NF is not nutritionally disadvantageous. 
7. Microbiological information on the novel food 
The microbiological status of the bread is mainly determined by the thermal treatment in the course of 
the baking processing. The application of the UV treatment after baking is not expected to introduce 
any additional microbiological contamination. Rather, it is expected to reduce potential 
contaminations, e.g. mould spores from the air, which may occur during the cooling phase of the 
process. 
The Panel considers that the data provided do not give rise to concerns with regard to the 
microbiological quality of the NF. 
8. Toxicological information on the novel food 
The applicant has not carried out toxicological studies on the NF. 
8.1. Vitamin D2 content 
Tolerable upper intake levels for vitamin D have been set as 25 μg/day for infants (up to one year of 
age), 50 μg/day for children from 1 to 10 years of age, 100 μg/day for adolescents from 11 to 17 years 
of age and 100 μg/day for adults (EFSA NDA Panel, 2012). Based on the estimated intake scenarios 
(Section 4), the applicant calculated that vitamin D2 intake from UV-treated bread would represent up 
to 10 to 15 % of the tolerable upper intake levels, depending on the age group (Section 6). 
8.2. Effect of the UV treatment on bread constituents and potential toxicity thereof 
It is known that UV treatment can induce oxidation reactions of macromolecules, such as fat or 
proteins. UVB exposure could induce radical formation of aromatic amino acids (e.g. tryptophan, 
tyrosine and phenylalanine) triggering redox processes with reactive residues and subsequently the 
formation of cross-links. 
Oxidative species have been shown to be generated from fructose upon UV treatment (Elsinghorst and 
Tikekar, 2014). The formation of furan, one of the final photolysis products, was induced by UV 
treatment of apple cider. In freshly prepared apple cider, no furan was formed at a UVC dose of 
1.8 J/cm
2
; at a dose of 8.8 J/cm
2
 the concentration of furan amounted to about 60 µg/l (Fan and 
Geveke, 2007). The formation of furan was also demonstrated in UV-treated simulated fruit juices 
sweetened with high-fructose corn syrup (Bule et al., 2010). According to analytical data provided by 
the applicant, the contents of fructose in types of bread intended for UV treatment ranged from 0.8 to 
5.2 g/100 g. Upon request by EFSA, the applicant provided data demonstrating that in two UV-treated 
breads containing 0.46 µg vitamin D2/100 g and 6.8 µg vitamin D2/100 g, respectively, furan was not 
detectable (˂ 5.0 µg/kg). 
One Member State raised concerns with respect to the mutagenicity observed in vitro for UV-treated 
maltol, a compound present in bread crust (Watanabe-Akanuma et al., 2007). In this study, untreated 
maltol was not mutagenic up to 5 mg/plate in the Ames test. When maltol was treated with either 
UVA (320–400 nm, 230 μW/cm2) for 5–30 minutes or UVC (610 μW/cm2) for three minutes in 
sodium phosphate buffer (pH 7.4) prior to the exposure of bacterial cells, it was found to be mutagenic 
to Salmonella typhimurium strains TA100, TA104 and TA97. Taking the mutagenicity observed after 
UVA treatment in 100 mM sodium-phosphate buffer (pH 7.4) as reference, higher relative 
mutagenicity was observed under neutral and alkaline conditions (pH 6.5–8.9), while lower relative 
mutagenicity was observed under acidic conditions (pH 5.5–6.0). Maltol treated with UVC in 100 nM 
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sodium chloride (NaCl) was found to be mutagenic, whereas no mutagenicity was observed when 
maltol was treated with UVA in 100 mM NaCl solution (pH 6.0) or water. Addition of thiol 
compounds (cysteine or glutathione, 200 μg/well, dissolved in sodium phosphate buffer, pH 7.4) to the 
UVA-irradiated maltol diminished the mutagenicity by 80 %. The Panel notes that the mutagenic 
effect for UV-treated maltol observed in vitro was highly dependent on the experimental conditions, 
i.e. UV wavelength, radiation time and dose, liquid matrix, pH, absence of thiol compounds. These 
conditions do not occur when applying the intended UV treatment to bread. Therefore, the Panel does 
not consider this observation relevant for the NF. 
The UV-induced conversion of ergosterol to vitamin D2 is accompanied by isomerisations resulting in 
tachysterol and lumisterol (Havinga et al., 1960). The formation of these by-products has also been 
observed following UV treatment of mushrooms (Kalaras et al., 2012; Keegan et al., 2013). After UV 
treatment of baker´s yeast the average amounts of vitamin D2 and tachysterol in the resulting yeast 
concentrate were 750 µg/g and 140 µg/g, respectively (EFSA NDA Panel, 2014). Assuming similar 
proportions of these substances upon UV treatment of bread, the applicant calculated that the intended 
maximum level of vitamin D2 (3 µg/100 g bread) would result in 0.6 µg tachysterol/100 g bread. This 
is lower than 0.93 µg/100 g bread expected from the use of vitamin D2-enriched UV-treated baker´s 
yeast, which did not give rise to safety concerns (EFSA NDA Panel, 2014). 
For vegetable oils, the UV-induced formation of β-sitosterol oxidation products has been described 
(Zhang et al., 2006). After an exposure time of 21 hours (light intensity 765 W/m
2
; 300–800 nm), 
between 5 % (sunflower oil) and 12 % (rapeseed oil) of β-sitosterol had been oxidized. Respective 
data for solid foods, such as bread, are lacking. 
The contents of total phytosterols reported in bread range from 40.5 mg/100 g dry weight (white 
bread) to 80.3 mg/100 g dry weight (rye bread made from rye and wheat flour) and 90.2 mg/100 g dry 
weight (rye bread made only from rye flour) (Piironen et al., 2002). Assuming that the maximum 
oxidation rate for phytosterols upon UV treatment is in the same order of magnitude as the maximum 
oxidation rate (1 %) reported for phytosterols following thermal processing (Scholz et al., 2015), 
phytosterol oxidation products expected in bread as a result of the UV treatment would amount to, 
approximately, 0.4–0.9 mg/100 g dry weight. Taking into account the short time of the UV treatment 
and the fact that UV-induced oxidations would occur in only the outer layer of the bread, the 
formation of phytosterol oxidation products is not considered to be of relevance. 
The Panel considers that the available data on potential effects of UV treatment on several compounds 
present in bread do not give rise to safety concerns. 
9. Allergenicity 
The Panel considers that the risk of allergic reactions to the NF is not dissimilar to that associated with 
conventional bread. 
DISCUSSION 
According to the compositional data provided, specified levels of vitamin D2 can be reproducibly 
achieved by UV treatment of bread. However, the applicant emphasized that the process has to be set 
up and specifically standardised depending on the characteristics of the bread. Adequate testing should 
be performed each time the process is applied for commercial scale operation.  
The Panel is aware that, under certain conditions, UV treatment may result in reactions of 
biomolecules, such as lipids or proteins. However, the reactions potentially induced by the UV 
treatment have to be considered in the light of the preceding baking process. The levels of potential 
reaction products that may be formed under the employed conditions from UV-induced oxidative 
reactions are low compared with the reactions induced by the baking process. Therefore, the Panel 
considers that it is not necessary to perform additional analyses and that the absence of toxicological 
studies with the novel food is acceptable. 
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Even if it is conservatively assumed that all consumed breads are UV treated and contain 3 µg 
vitamin D2/100 g, it is highly unlikely that tolerable upper intake levels established by EFSA (EFSA 
NDA Panel, 2012) will be exceeded. 
CONCLUSIONS 
The Panel considers that bread enriched with vitamin D2 through UV treatment is safe under the 
conditions of use as specified by the applicant. 
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3. Member States’ comments and objections. 
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objections. 
5. Letter from the European Commission to the European Food Safety Authority with the request for 
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